問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2019-01-01 - 2020-12-31
Condition/Disease
Alzheimer's disease
Test Drug
18F-PMPBB3
Participate Sites2Sites
Recruiting2Sites
2019-08-01 - 2021-07-31
investigate the deposition patterns of tau protein with 18F-PM-PBB3 and amyloid protein with 18F-flobetapir in patients with amnestic mild cognitive impairment due to AD
18F-AV-45 for Injection, and 18F-PM-PBB3 for Injection
Participate Sites1Sites
Recruiting1Sites
2019-08-01 - 2022-07-31
*PRESENILE DEMENTIA;SENILE DEMENTIA, UNCOMPLICATED;DEMENTIA IN CONDITIONS CLASSIFIED ELSEWHERE;AMNESTIC SYNDROME
(1)[F18] AV-45 (2) [F-18] PM-PBB3
Participate Sites3Sites
Recruiting3Sites
2018-09-21 - 2028-11-30
2019-08-01 - 2024-07-31
2019-08-01 - 2022-10-31
2019-01-01 - 2023-12-31
2020-01-01 - 2023-12-31
Progressive Supranuclear Palsy
18F-PMPBB3 (別名APN-1607, MNI-958, or APN-0000455)
2017-01-01 - 2019-12-31
Prostate Adenocarcinoma
[11C]Choline ([11C]Methyl-dimethyl-2-hydroxyethyl-ammonium), Glass vial with 40-331mCi of 11C choline in aqueous 0.9% sodium
2016-07-01 - 2023-05-09
全部
